The brain is the most frequent site of crippling and incurable human disease. Neurosurgeons are ideally positioned to advance and translate neuroscience discoveries, but it is a stark minority that are able to build a career as a physician-scientist successfully. Training programs, including our own, have been deficient in their provision of three essential components to delivering neurosurgeon-scientists to the field: 1) Opportunity; 2) Mentorship; 3) Continuity. We have examined the difficult truth of poor productivity from our prior R25 awardees, dissected our failures, and designed new and innovative programmatic approaches, specifically molded to 1) expand opportunities; 2) re-address mentorship; and 3) redefine entirely the look of sustained departmental commitment to developing and maintaining neurosurgeon-scientists. Herein, we offer a fresh enthusiasm, focus, and approach for addressing the problem of how to deliver and sustain neurosurgical research contributions. The program proposed here provides a unique and organized approach to engage, support, and maintain neurosurgery trainees in mentored research. Our hypothesis is that implementation of a formal physician- scientist training track, coupled with a committee-based mentored research experience and an unprecedented commitment to longitudinal support for trainees who secure funding will result in improved realization of independently-funded academic careers for neurosurgeon-scientists. Toward that end, our Specific Aims are to optimize/provide: 1. Opportunity. Our neurosurgery residency has been re-designed to include a Physician-Scientist Track that proffers a weekly Academic Day during junior residency, a PhD-thesis style Research Mentorship Committee, a core curriculum, a vetted and reviewed R25 application, mentored/supported research PGY years 4-6, and a 7th ?transition to practice? year that teaches trainees to divide time successfully between clinical and research responsibilities. 2. Mentorship. Physician-Scientist Track residents will identify a primary research mentor from among 29 approved Duke faculty mentors grouped into 9 distinct Research Concentrations. A PhD-style Research Mentorship Committee will be formed to mentor the resident throughout training. 3. Continuity. R25 recipients will receive matched funds from Neurosurgery to support their research endeavors during the clinical years separating their R25 award in PGY4 from the PGY7 ?transition to practice? year.

Public Health Relevance

The current design of neurosurgical residencies and changes to training priorities have imposed troublesome restrictions on our ability to foster and retain neurosurgeon-scientists. This proposal describes an innovative program to cultivate and maintain the interest and capability of neurosurgeon-scientists by providing newly formatted opportunities, mentorship, and continuity. Our residency has been specifically redesigned to recruit, train, and propel neurosurgeon-scientists into an NIH-funded academic career.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Education Projects (R25)
Project #
2R25NS065731-11A1
Application #
9853428
Study Section
Special Emphasis Panel (ZNS1)
Program Officer
Korn, Stephen J
Project Start
2009-03-01
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
11
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Duke University
Department
Neurosurgery
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Guercio, Jason R; Kralic, Jason E; Marrotte, Eric J et al. (2018) Spinal cord injury pharmacotherapy: Current research & development and competitive commercial landscape as of 2015. J Spinal Cord Med :1-48
Atik, Ahmet F; Suryadevara, Carter M; Schweller, Ryan M et al. (2018) Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells. J Clin Neurosci 56:163-168
Swan, Brandon D; Gasperson, Lynne B; Krucoff, Max O et al. (2018) Sensory percepts induced by microwire array and DBS microstimulation in human sensory thalamus. Brain Stimul 11:416-422
Batich, Kristen A; Reap, Elizabeth A; Archer, Gary E et al. (2017) Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. Clin Cancer Res 23:1898-1909
Krucoff, Max O; Zhuang, Katie; MacLeod, David et al. (2017) A novel paraplegia model in awake behaving macaques. J Neurophysiol 118:1800-1808
Krucoff, Max O; Chan, Alvin Y; Harward, Stephen C et al. (2017) Rates and predictors of success and failure in repeat epilepsy surgery: A meta-analysis and systematic review. Epilepsia 58:2133-2142
Suryadevara, Carter M; Riccione, Katherine A; Sampson, John H (2016) Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity. Clin Cancer Res 22:5164-5166
Krucoff, Max O; Rahimpour, Shervin; Slutzky, Marc W et al. (2016) Enhancing Nervous System Recovery through Neurobiologics, Neural Interface Training, and Neurorehabilitation. Front Neurosci 10:584
Subashi, Ergys; Cordero, Francisco J; Halvorson, Kyle G et al. (2016) Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma. J Neurooncol 126:243-51
Preusser, Matthias; Lim, Michael; Hafler, David A et al. (2015) Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nat Rev Neurol 11:504-14

Showing the most recent 10 out of 27 publications